<!DOCTYPE html>
<html lang="en">
    <head>
        <title>displaCy</title>
    </head>

    <body style="font-size: 16px; font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol'; padding: 4rem 2rem; direction: ltr">
<figure style="margin-bottom: 6rem">
<div class="entities" style="line-height: 2.5; direction: ltr">The patient, a 68-year-old male with a medical history of hypertension, type 2 diabetes, and hyperlipidemia, presented with complaints of persistent fatigue, shortness of breath, and intermittent chest pain. Initial assessment in the Emergency Department revealed elevated blood pressure of 160/90 mmHg, blood glucose of 
<mark class="entity" style="background: #42d4f4; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    230 mg/dL
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
, and total cholesterol levels above the normal range. An electrocardiogram (ECG) showed sinus rhythm with occasional premature atrial contractions. Upon admission to the Cardiology ward, the patient underwent further diagnostic tests, including a stress test and echocardiogram. The stress test revealed exercise-induced ischemia, and the echocardiogram displayed mild left ventricular hypertrophy with preserved ejection fraction. Based on these findings, the patient was diagnosed with stable angina and uncontrolled hypertension. Treatment commenced with anti-anginal medications, including 
<mark class="entity" style="background: #f032e6; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    sublingual
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #3cb44b; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nitroglycerin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 and 
<mark class="entity" style="background: #3cb44b; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    beta-blockers
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
, along with antihypertensive drugs to optimize blood pressure control. Lifestyle modifications, such as dietary changes and regular exercise, were recommended. The patient was also started on a 
<mark class="entity" style="background: #3cb44b; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    statin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 for lipid management. Throughout the hospital stay, the patient's blood pressure and blood glucose levels were closely monitored, and adjustments to the medication regimen were made accordingly. The patient's symptoms improved, and he reported decreased episodes of chest pain and improved exercise tolerance. Upon discharge, the patient was prescribed a comprehensive medication regimen, including 
<mark class="entity" style="background: #3cb44b; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    aspirin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
, 
<mark class="entity" style="background: #3cb44b; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    metoprolol
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
, 
<mark class="entity" style="background: #3cb44b; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    amlodipine
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
, 
<mark class="entity" style="background: #3cb44b; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    atorvastatin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
, and 
<mark class="entity" style="background: #3cb44b; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    metformin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
. Follow-up appointments with both the Cardiology and Endocrinology clinics were scheduled to ensure ongoing management of his cardiovascular and metabolic conditions. The patient was educated on the importance of adherence to medications, lifestyle modifications, and regular follow-ups. A personalized care plan was established to address the specific needs and risk factors of the patient, aiming to optimize his long-term cardiovascular health.</div>
</figure>
</body>
</html>